130 related articles for article (PubMed ID: 29861596)
1. An Ayurvedic treatment protocol to improve anti-mullerian hormone: A prerequisite for assisted reproductive technique- A case report.
Muraleedharan A; Unnikrishnan P; Narayan P; Krishnarajabhatt HS
Ayu; 2017; 38(1-2):66-69. PubMed ID: 29861596
[TBL] [Abstract][Full Text] [Related]
2. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
[TBL] [Abstract][Full Text] [Related]
3. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.
Baarends WM; Uilenbroek JT; Kramer P; Hoogerbrugge JW; van Leeuwen EC; Themmen AP; Grootegoed JA
Endocrinology; 1995 Nov; 136(11):4951-62. PubMed ID: 7588229
[TBL] [Abstract][Full Text] [Related]
4. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
[TBL] [Abstract][Full Text] [Related]
5. [Anti mullerian hormone (AMH)--is it a new reliable marker of the ovarian reserve? Its role in predicting the ovarian response in assisted reproductive technology (ART)].
Alshiek JA; Lessing JB; Amit A; Azem F
Harefuah; 2012 Jul; 151(7):416-20, 435. PubMed ID: 23002694
[TBL] [Abstract][Full Text] [Related]
6. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
[TBL] [Abstract][Full Text] [Related]
7. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
8. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
[TBL] [Abstract][Full Text] [Related]
9. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
10. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
12. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
[TBL] [Abstract][Full Text] [Related]
14. Discordance between antral follicle counts and anti-Müllerian hormone levels in women undergoing in vitro fertilization.
Zhang Y; Xu Y; Xue Q; Shang J; Yang X; Shan X; Kuai Y; Wang S; Zeng C
Reprod Biol Endocrinol; 2019 Jul; 17(1):51. PubMed ID: 31272468
[TBL] [Abstract][Full Text] [Related]
15. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
16. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
[TBL] [Abstract][Full Text] [Related]
17. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
18. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
19. The impact of the localisation of endometriosis lesions on ovarian reserve and assisted reproduction techniques outcomes.
Ashrafi M; Arabipoor A; Hemat M; Salman-Yazdi R
J Obstet Gynaecol; 2019 Jan; 39(1):91-97. PubMed ID: 30257599
[TBL] [Abstract][Full Text] [Related]
20. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment.
Meczekalski B; Czyzyk A; Kunicki M; Podfigurna-Stopa A; Plociennik L; Jakiel G; Maciejewska-Jeske M; Lukaszuk K
J Endocrinol Invest; 2016 Nov; 39(11):1259-1265. PubMed ID: 27300031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]